Immunological analysis of the combination therapy of nivolumab, paclitaxel and bevacizumab in patients with HER2negative MBC in NEWBEAT trial (WJOG9917BTR)

被引：0

作者：

Ozaki, Yukinori ^{[1
]}

Kitano, Shigehisa ^{[2
]}

Tsurutani, Junji ^{[3
]}

Iwasa, Tsutomu ^{[4
]}

Takahashi, Masato ^{[5
]}

Mukohara, Toru ^{[6
]}

Masuda, Norikazu ^{[7
]}

Futamura, Manabu ^{[8
]}

Minami, Hironobu ^{[9
]}

Matsumoto, Koji ^{[10
]}

Kawabata, Hidetaka ^{[11
]}

Yamashita, Makiko ^{[2
]}

Yoshimura, Kenichi ^{[12
]}

Takano, Toshimi ^{[1
]}

机构：

[1] JFCR, Toranomon Hosp, Canc Inst Hosp, Tokyo, Japan

[2] JFCR, Canc Inst Hosp, Tokyo, Japan

[3] Showa Univ, Adv Canc Translat Res Inst, Tokyo, Japan

[4] Kindai Univ, Fac Med, Osaka, Japan

[5] NHO Hokkaido Canc Ctr, Sapporo, Hokkaido, Japan

[6] Natl Canc Ctr Hosp East, Kashiwa, Chiba, Japan

[7] Natl Hosp Org Osaka Natl Hosp, Osaka, Japan

[8] Gifu Univ, Gifu, Japan

[9] Kobe Univ, Sch Med, Kobe, Hyogo, Japan

[10] Hyogo Canc Ctr, Akashi, Hyogo, Japan

[11] Toranomon Gen Hosp, Tokyo, Japan

[12] Hiroshima Univ Hosp, Hiroshima, Japan

来源：

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

PS4-14

引用

页数：1